BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the launch of the V4 Sequencing Kit. The new kit is compatible with both the Platinum® and Platinum® Pro instruments. The V4 Sequencing Kit improves sequencing coverage with the addition of glycine (G) recognition, […]
BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant new collaboration with Jessa Ziekenhuis in Hasselt, Belgium. The institutions will partner to bring cutting edge genomic testing and oncology research to cancer patients across Belgium. Jessa Ziekenhuis, one of Belgium’s largest healthcare […]
A new Hereditary Cancer Panel will interrogate 258 genes associated with inherited cancer risk Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, has launched a comprehensive Hereditary Cancer Panel (HCP), which will allow users to interrogate 258 key genes associated with inherited cancer risk. The HCP provides a simple […]
Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease Following early access program, customers commend scale, high consistency, and easy sample to insights workflow Launch follows Illumina’s announcement of agreement to acquire SomaLogic SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced the […]
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that EpiCypher, a recognized leader in epigenetics tools, has joined the […]
Durham, NC – EpiCypher®, a pioneer in epigenomic research and technology, announces the launch of CUTANA® Fiber-seq, a groundbreaking multiomic genomics platform that captures both genomic and epigenomic information in a single long-read sequencing assay. This first-of-its-kind technology delivers unprecedented resolution of DNA sequence and chromatin features along individual DNA molecules, opening an entirely new dimension […]
A new Hereditary Cancer Panel will interrogate 258 genes associated with inherited cancer risk Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, has launched a comprehensive Hereditary Cancer Panel (HCP), which will allow users to interrogate 258 key genes associated with inherited cancer risk. The HCP provides a simple […]
Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint – servicing over 160 labs in 30+ countries The acquisition creates the largest global ‘software pure player’ in the clinical genomics space, which will maintain UK presence at the renowned Wellcome Sanger Institute MONTPELLIER, France, and CAMBRIDGE, UK: SeqOne, a pioneer in […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has collaborated with next generation therapeutics company, Synthetic Design Lab (SDL). “With our high throughput expertise, from novel binder discovery services to high throughput screening capabilities, we’re able to support researchers working to unlock novel engineered therapeutics,” […]
BOZEMAN, Mont. — Golden Helix, a global leader in clinical bioinformatics, today announced a strategic partnership with Genomenon to integrate its Mastermind Genomic Intelligence Platform and Cancer Knowledgebase (CKB) into the Golden Helix software suite. This collaboration combines two industry-leading platforms to enhance genomic interpretation and deliver high-confidence, literature-backed insights to clinical laboratories worldwide. Through […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
